Table 2.
Drug | Timing | Trough Drug Concentrations (μg/mL) Associated with Outcome’s Improvement | Outcome Measure |
---|---|---|---|
UST | Induction (Week 8) | >3–7 | Clinical |
UST | Maintenance | >1–3 | Clinical/Endoscopic |
VDZ | Induction (Week 6) | >33–37 | Clinical/Endoscopic |
VDZ | End of induction (Week 14) |
>15–20 | |
VDZ | Maintenance | >10–15 | Clinical/Endoscopic |